KO vs MYGN · P/E 25, rev $47.94B vs rev $837.6M
The Coca-Cola Company (KO) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the KO and MYGN stock pages for the full models.
Not investment advice.